We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
+13.49%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.37B
AUM Growth
+$167M
Cap. Flow
+$24.1M
Cap. Flow %
1.76%
Top 10 Hldgs %
57.21%
Holding
359
New
25
Increased
120
Reduced
185
Closed
27

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$19.7M
2
PDD icon
Pinduoduo
PDD
+$16.1M
3
NIO icon
NIO
NIO
+$12.8M
4
MRVL icon
Marvell Technology
MRVL
+$11M
5
TSM icon
TSMC
TSM
+$10.1M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$23.6M
2
LEGN icon
Legend Biotech
LEGN
+$19.4M
3
TCOM icon
Trip.com Group
TCOM
+$15.4M
4
ZLAB icon
Zai Lab
ZLAB
+$8.54M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.1%
2 Technology 29.22%
3 Communication Services 14%
4 Healthcare 8.72%
5 Real Estate 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LMT icon
301
Lockheed Martin
LMT
$134B
$200K 0.01%
424
-30
-7% -$14.1K
PTGX icon
302
Protagonist Therapeutics
PTGX
$8.72B
$200K 0.01%
8,713
-6,769
-44% -$114K
ICPT
303
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$199K 0.01%
14,790
+858
+6% +$14.8K
KURA icon
304
Kura Oncology
KURA
$901M
$191K 0.01%
15,588
-1,585
-9% -$19.8K
ALLO icon
305
Allogene Therapeutics
ALLO
$604M
$190K 0.01%
38,437
-1,208
-3% -$7.75K
ARQT icon
306
Arcutis Biotherapeutics
ARQT
$3.48B
$190K 0.01%
17,299
+1,419
+9% +$20.5K
AGEN
307
Agenus
AGEN
$255M
$188K 0.01%
6,310
+1,637
+35% +$69.2K
CDMO
308
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$188K 0.01%
10,037
-6,691
-40% -$110K
ADMA icon
309
ADMA Biologics
ADMA
$1.97B
$184K 0.01%
55,703
+14,327
+35% +$49.5K
CHRS icon
310
Coherus Oncology
CHRS
$225M
$156K 0.01%
22,741
-1,846
-8% -$14.3K
COGT icon
311
Cogent Biosciences
COGT
$6.91B
$148K 0.01%
13,749
-3,226
-19% -$41.3K
DAWN
312
DELISTED
Day One Biopharmaceuticals
DAWN
$145K 0.01%
10,867
+103
+1% +$2.01K
RXRX icon
313
Recursion Pharmaceuticals
RXRX
$1.6B
$143K 0.01%
21,417
-5,694
-21% -$45.2K
SIRI icon
314
SiriusXM
SIRI
$10.5B
$138K 0.01%
3,465
-230
-6% -$11K
LCID icon
315
Lucid Motors
LCID
$2.54B
$131K 0.01%
1,630
+34
+2% +$3.02K
TSVT
316
DELISTED
2seventy bio
TSVT
$129K 0.01%
+12,601
New +$144K
ALT icon
317
Altimmune
ALT
$576M
$124K 0.01%
29,334
-1,952
-6% -$23.2K
EQRX
318
DELISTED
EQRx, Inc. Common Stock
EQRX
$121K 0.01%
62,580
-1,845
-3% -$4.2K
VTRS icon
319
Viatris
VTRS
$20.5B
$114K 0.01%
11,886
-408
-3% -$4.53K
MRSN
320
DELISTED
Mersana Therapeutics
MRSN
$113K 0.01%
1,103
+229
+26% +$32.1K
INO icon
321
Inovio Pharmaceuticals
INO
$79.4M
$106K 0.01%
10,774
-533
-5% -$9.09K
ALLK
322
DELISTED
Allakos
ALLK
$95K 0.01%
21,450
+4,701
+28% +$30.1K
ATRA icon
323
Atara Biotherapeutics
ATRA
$69.5M
$93K 0.01%
1,282
+228
+22% +$22.1K
VNDA icon
324
Vanda Pharmaceuticals
VNDA
$314M
$89K 0.01%
+13,060
New +$91.8K
ALEC icon
325
Alector
ALEC
$168M
$87K 0.01%
14,089
+3,198
+29% +$26K
11 12
13
14 15

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

E Fund Management's Q1 2023 Portfolio in Review

As of Q1 2023, E Fund Management held 359 positions worth $1.37B, up 14% from $1.2B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

E Fund Management's Q1 2023 filing shows 25 new, 120 increased, 185 reduced and 27 closed positions. Its largest new stake was Alibaba: 31,628 shares worth $3.23M. The largest sale was Qualcomm, an estimated $23.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, down from 37% a quarter earlier, followed by Technology and Communication Services.

  • E Fund Management's largest Q1 2023 buy was Alibaba: 31,628 shares worth $3.23M.
  • E Fund Management added most to Microsoft in Q1 2023, an estimated $19.7M increase.
  • E Fund Management's biggest Q1 2023 reduction was Qualcomm, cutting an estimated $23.6M.
  • E Fund Management fully exited United States Brent Oil Fund in Q1 2023, selling an estimated $1.75M.
  • E Fund Management's ten largest holdings make up 57% of its $1.37B portfolio in Q1 2023.
  • E Fund Management opened 25 new positions and closed 27 in Q1 2023.
  • E Fund Management's portfolio value rose 14% quarter-over-quarter to $1.37B.

Based on E Fund Management's 13F filing for Q1 2023, filed 11 May 2023.